Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03679585
Other study ID # i 44717
Secondary ID NCI-2018-00023i
Status Completed
Phase N/A
First received
Last updated
Start date May 31, 2017
Est. completion date August 13, 2018

Study information

Verified date July 2022
Source Roswell Park Cancer Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical trial studies how well Talking Pictures social media intervention works in reducing depressive symptoms and improving spiritual well-being and quality of life in adolescent and young adult cancer patients. Talking Pictures social media intervention may help doctors better learn how to most effectively provide psychosocial support to adolescent and young adult cancer patients.


Description:

PRIMARY OBJECTIVES: I. To determine the feasibility and acceptability of a 10-week application (app)-based intervention. II. To assess the impact of the intervention on depressive symptoms, spiritual well-being and quality of life. III. To examine the content of participants recorded narratives for salient themes related to weekly content areas (e.g. identity, meaning-making, hopes, fears) in order to better understand the unique experiences and challenges of adolescent and young adult (AYA) patients. OUTLINE: Participants undergo Talking Pictures social media intervention for 10 weeks, receiving weekly assignments via email with requirements to use the Pixstori app to take and upload photographs with verbal narratives attached to a website. Participants can then share their pixstories to a group page and view and respond to others' pixstories. After completion of study, participants are followed up at 2 months.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date August 13, 2018
Est. primary completion date August 13, 2018
Accepts healthy volunteers No
Gender All
Age group 15 Years to 34 Years
Eligibility Inclusion Criteria: - Adolescent and young adult cancer patients who were diagnosed within three years - English comprehension in written and oral format - Current possession of a smartphone, tablet, or computer with camera and wifi capacity or data plan - Valid email address - Pregnant women will be included if they meet eligibility requirements Exclusion Criteria: - Diagnosis of mental retardation, severe or untreated psychopathology (e.g. schizophrenia), or dementia - Adults unable to consent: Will not include - Prisoners will not be included given lack of access to smartphone

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Internet-Based Intervention
Undergo Talking Pictures social media intervention
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies

Locations

Country Name City State
United States Roswell Park Cancer Institute Buffalo New York

Sponsors (1)

Lead Sponsor Collaborator
Roswell Park Cancer Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weekly photo task completion rate The observed completion rate will be described using the binomial completion proportion and its 2-sided 95% Jeffries confidence interval. At 10 weeks
Primary Project participation rates Study will be deemed feasible it least 11 of 30 participants demonstrate completion of assignments At 10 weeks
Primary Impact of intervention on depressive symptoms as assessed by Beck Depression Inventory-II (BDI-II) total score A series of repeated questionnaires will be conducted. Up to 2 months post intervention
Primary Impact of intervention on spiritual well-being as assessed by Functional Assessment of Chronic Illness Therapy Spiritual Well-Being (FACIT-Sp) total score A series of repeated questionnaires will be conducted. Up to 2 months post intervention
Primary Impact of intervention on psychosocial quality of life as assessed by Pediatric Quality of Life Inventory-Adolescent and Young Adult (PedsQL-AYA) psychosocial health score A series of questionnaires will be conducted. Up to 2 months post intervention
Secondary Participant satisfaction rating Satisfaction Questionnaire to be conducted At 10 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Active, not recruiting NCT02243592 - Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
Completed NCT03445572 - Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With Cancer N/A
Active, not recruiting NCT02860039 - High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant Phase 2
Completed NCT01946217 - Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials N/A
Completed NCT01635413 - Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial) N/A
Completed NCT00026169 - Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure Phase 1
Recruiting NCT04534075 - Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial Phase 3
Active, not recruiting NCT01806129 - Reproductive Health Program in Patients With Cancer N/A
Recruiting NCT03915717 - Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring
Recruiting NCT02280161 - Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Recruiting NCT05520281 - Short-term Psychodynamic Psychotherapy in Serious Physical Illness N/A
Terminated NCT00532064 - Cardiac Biomarkers in Early Detection of Cardiotoxicity in Patients Receiving Sunitinib or Sorafenib Chemotherapy
Completed NCT04990882 - FAPI PET/CT Prospective Interobserver Agreement
Completed NCT01896778 - Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer N/A
Recruiting NCT05770102 - DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition Phase 2/Phase 3
Recruiting NCT06090266 - A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Recruiting NCT05886764 - Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials N/A
Completed NCT01506440 - Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy
Completed NCT01432431 - Spiritual Care in Improving Quality of Life of Patients, Caregivers, and Hospital Staff N/A